74 related articles for article (PubMed ID: 9357514)
41. Preferential expression of 5-HT1D over 5-HT1B receptors during murine embryonic development.
Bolaños-Jiménez F; Choi DS; Maroteaux L
Ann N Y Acad Sci; 1998 Dec; 861():238-9. PubMed ID: 9928264
[No Abstract] [Full Text] [Related]
42. Commentary on the article presented by Murdoch et al.
Fillion G
Br J Pharmacol; 2003 Mar; 138(5):731. PubMed ID: 12642372
[No Abstract] [Full Text] [Related]
43. 3-(2-pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT(1B/1D) ligands.
Egle I; MacLean N; Demchyshyn L; Edwards L; Slassi A; Tehim A
Bioorg Med Chem Lett; 2004 Feb; 14(3):727-9. PubMed ID: 14741277
[TBL] [Abstract][Full Text] [Related]
44. Modulation of noradrenaline release in human cardiovascular tissues.
Göthert M
Pharmacol Toxicol; 2003 Apr; 92(4):156-9. PubMed ID: 12753416
[No Abstract] [Full Text] [Related]
45. High level expression of the human 5-HT1D alpha serotonin receptor using the Semliki Forest Virus expression system.
Stables J; Rees S; Lundstrom K; Livingstone D; Lee MG
Ann N Y Acad Sci; 1997 May; 812():229-30. PubMed ID: 9186753
[No Abstract] [Full Text] [Related]
46. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review.
Corkery JM; Elliott S; Schifano F; Corazza O; Ghodse AH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):253-8. PubMed ID: 22687464
[TBL] [Abstract][Full Text] [Related]
47. Piperidine and pyrrolidine analogs as glycogen synthase activators; a patent evaluation (WO2011058122).
Uto Y
Expert Opin Ther Pat; 2012 Jan; 22(1):89-93. PubMed ID: 22214327
[TBL] [Abstract][Full Text] [Related]
48. Piperidine: a new neuromodulator or a hypogenic substance?
Giacobini E
Adv Biochem Psychopharmacol; 1976; 15():17-56. PubMed ID: 15412
[No Abstract] [Full Text] [Related]
49. Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres.
Obach RS; LaChapelle EA; Brodney MA; Vanase-Frawley M; Kauffman GW; Sawant-Basak A
Xenobiotica; 2016 Dec; 46(12):1112-1121. PubMed ID: 26947511
[TBL] [Abstract][Full Text] [Related]
50. [Relation between structure and action in a series of some cyclic compounds comprising phenylethylamine grouping].
Starykh NT; Krylov SS; El'tsov AV; Chigarev AG
Farmakol Toksikol; 1966; 29(1):25-31. PubMed ID: 5988612
[No Abstract] [Full Text] [Related]
51. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
52. Eletriptan Pfizer.
Strijbos PJ; Parsons AA; Fugelli A
Curr Opin Investig Drugs; 2002 Sep; 3(9):1359-68. PubMed ID: 12498013
[TBL] [Abstract][Full Text] [Related]
53. 3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.
Castro JL; Street LJ; Guiblin AR; Jelley RA; Russell MG; Sternfeld F; Beer MS; Stanton JA; Matassa VG
J Med Chem; 1997 Oct; 40(22):3497-500. PubMed ID: 9357514
[No Abstract] [Full Text] [Related]
54. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
[TBL] [Abstract][Full Text] [Related]
55. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of oral absorption in selective 5-HT1D receptor agonists: fluorinated 3-[3-(piperidin-1-yl)propyl]indoles.
Castro JL; Collins I; Russell MG; Watt AP; Sohal B; Rathbone D; Beer MS; Stanton JA
J Med Chem; 1998 Jul; 41(15):2667-70. PubMed ID: 9667955
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
